SAVA Cassava Sciences Inc

Price (delayed)

$12.06

Market cap

$578.59M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.16

Enterprise value

$454.42M

Cassava Sciences' mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to ...

Highlights
The net income has soared by 51% from the previous quarter and by 42% YoY
Cassava Sciences's EPS has soared by 50% from the previous quarter and by 43% YoY
The quick ratio has dropped by 88% year-on-year and by 81% since the previous quarter
Cassava Sciences's equity has plunged by 61% YoY and by 43% from the previous quarter

Key stats

What are the main financial stats of SAVA
Market
Shares outstanding
47.98M
Market cap
$578.59M
Enterprise value
$454.42M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.63
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$47.9M
EBITDA
-$46.45M
Free cash flow
-$87.95M
Per share
EPS
-$1.16
Free cash flow per share
-$2.05
Book value per share
$1.82
Revenue per share
$0
TBVPS
$3.62
Balance sheet
Total assets
$155.72M
Total liabilities
$77.12M
Debt
$0
Equity
$78.6M
Working capital
$56.88M
Liquidity
Debt to equity
0
Current ratio
1.74
Quick ratio
1.61
Net debt/EBITDA
2.67
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-28.3%
Return on equity
-34.8%
Return on invested capital
N/A
Return on capital employed
-60.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SAVA stock price

How has the Cassava Sciences stock price performed over time
Intraday
-6%
1 week
-10.86%
1 month
-39.76%
1 year
-44.17%
YTD
-46.42%
QTD
-2.35%

Financial performance

How have Cassava Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$99.38M
Net income
-$47.9M
Gross margin
N/A
Net margin
N/A
The net income has soared by 51% from the previous quarter and by 42% YoY
Cassava Sciences's operating income has decreased by 12% YoY but it has increased by 6% from the previous quarter

Growth

What is Cassava Sciences's growth rate over time

Valuation

What is Cassava Sciences stock price valuation
P/E
N/A
P/B
6.63
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Cassava Sciences's EPS has soared by 50% from the previous quarter and by 43% YoY
Cassava Sciences's equity has plunged by 61% YoY and by 43% from the previous quarter
SAVA's P/B is 12% above its 5-year quarterly average of 6.3

Efficiency

How efficient is Cassava Sciences business performance
Cassava Sciences's ROA has increased by 46% from the previous quarter and by 24% YoY
SAVA's return on equity is up by 39% since the previous quarter and by 11% year-on-year

Dividends

What is SAVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SAVA.

Financial health

How did Cassava Sciences financials performed over time
The total assets is 102% more than the total liabilities
The current ratio has plunged by 88% YoY and by 81% from the previous quarter
The quick ratio has dropped by 88% year-on-year and by 81% since the previous quarter
Cassava Sciences's debt is 100% less than its equity
Cassava Sciences's equity has plunged by 61% YoY and by 43% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.